These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The Norrköping study. Cephalosporins are often the implicating factors in Clostridium difficile infections]. Eriksson S; Aronsson B Lakartidningen; 1991 Oct; 88(41):3374, 3377, 3379. PubMed ID: 1921624 [TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents. Gianfrilli P; Luzzi I; Pantosti A; Occhionero M Chemioterapia; 1984 Feb; 3(1):41-4. PubMed ID: 6535652 [TBL] [Abstract][Full Text] [Related]
10. Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly. Starr JM; Impallomeni M Biomed Pharmacother; 1997; 51(2):63-7. PubMed ID: 9161469 [TBL] [Abstract][Full Text] [Related]
11. Role of cephalosporins in the era of Clostridium difficile infection. Wilcox MH; Chalmers JD; Nord CE; Freeman J; Bouza E J Antimicrob Chemother; 2017 Jan; 72(1):1-18. PubMed ID: 27659735 [TBL] [Abstract][Full Text] [Related]
12. Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Cefotaxime compares favourably with other third generation cephalosporins. Rothschild E; Rauss A; Danan G BMJ; 1996 Mar; 312(7033):778. PubMed ID: 8605486 [No Abstract] [Full Text] [Related]
13. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. Vardakas KZ; Trigkidis KK; Boukouvala E; Falagas ME Int J Antimicrob Agents; 2016 Jul; 48(1):1-10. PubMed ID: 27216385 [TBL] [Abstract][Full Text] [Related]
14. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China. Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941 [TBL] [Abstract][Full Text] [Related]
15. [Diarrhea associated with Clostridium difficile: one-year experience in a general hospital]. Bouza E; Padilla B; Catalán P; Sánchez-Carrillo C; Blázquez R; Peláez T Rev Clin Esp; 1996 Jul; 196(7):424-30. PubMed ID: 8804202 [TBL] [Abstract][Full Text] [Related]
16. Clinical epidemiology of Clostridium difficile infection among hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil. Lopes Cançado GG; Silveira Silva RO; Rupnik M; Nader AP; Starling de Carvalho J; Miana de Mattos Paixão G; Martins Resende BA; Faria Lobato FC; Vilela EG Anaerobe; 2018 Dec; 54():65-71. PubMed ID: 30114442 [TBL] [Abstract][Full Text] [Related]
17. Toxigenic Singh M; Vaishnavi C; Kochhar R; Mahmood S Indian J Med Res; 2017 Jun; 145(6):840-846. PubMed ID: 29067987 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for the development of Clostridium difficile toxin-associated diarrhoea: a pilot study. Aziz EE; Ayis S; Gould FK; Rawlins MD Pharmacoepidemiol Drug Saf; 2001; 10(4):303-8. PubMed ID: 11760491 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study. DiDiodato G; McArthur L PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]